https://www.selleckchem.com/ph....armacological_epigen
Etomidate is typically used as an induction agent in cardiac surgery because it has little impact on hemodynamics. It is a known suppressor of adrenocortical function and may increase the risk for post-operative infections, sepsis, and mortality. The aim of this study was to evaluate whether etomidate increases the risk of postoperative sepsis (primary outcome) and infections (secondary outcome) compared to propofol. This was a retrospective before-after trial (IRB EA1/143/2 performed at a tertiary medical center in Berlin,